Your browser doesn't support javascript.
loading
Network Pharmacology-Based Strategy Combined with Molecular Docking and in vitro Validation Study to Explore the Underlying Mechanism of Huo Luo Xiao Ling Dan in Treating Atherosclerosis.
Sun, Taoli; Quan, Wenjuan; Peng, Sha; Yang, Dongmei; Liu, Jiaqin; He, Chaoping; Chen, Yu; Hu, Bo; Tuo, Qinhui.
Afiliação
  • Sun T; School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China.
  • Quan W; School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China.
  • Peng S; School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China.
  • Yang D; School of Medicine, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China.
  • Liu J; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People's Republic of China.
  • He C; School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China.
  • Chen Y; School of Medicine, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China.
  • Hu B; School of Medicine, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China.
  • Tuo Q; School of Medicine, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China.
Drug Des Devel Ther ; 16: 1621-1645, 2022.
Article em En | MEDLINE | ID: mdl-35669282

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Aterosclerose Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Aterosclerose Idioma: En Ano de publicação: 2022 Tipo de documento: Article